EPCAM and cancer: Immunohistochemical analysis revealed that the staining intensity of EpCAM, and the relative area occupied by EpCAM-positive cancer cells were significantly higher in tumors of patients who received platinum-based chemotherapy than in those of matched patients who did not (P = 0.016; Figure 1E).